Andy Lundin, Author at Hematology Advancements

Ethical and Regulatory Implications of CRISPR in Hematology

Posted by Andy Lundin | Jul 11, 2024 | Innovations |

The application of CRISPR tech in hematology raises ethical and regulatory concerns that must be addressed to ensure safe and equitable use.

Collaborations between academic centers and hematology clinics are essential for advancing education and training in the field of hematology.

Lean management techniques are transforming hematology laboratories by optimizing workflows, reducing waste, and improving patient care.

Next-generation hematology analyzers offer enhanced capabilities that promise a substantial ROI for healthcare providers.

Posted by Andy Lundin | Jul 11, 2024 | Market Insights |

The global hematology market is poised for significant growth, driven by advancements in diagnostic technologies.